Brought to you by:
TCAR has ‘statistically equivalent’ stroke and death outcomes to CEA, new study finds
Silk Road Medical has announced positive results from an independent analysis of standard surgical risk patients undergoing carotid endarterectomy (CEA) and transcarotid artery revascularization (TCAR) for atherosclerotic carotid disease. The data were presented at the Society for Vascular Surgery (SVS) 2021 Vascular Annual Meeting…
Vascular surgeons as community leaders in vascular disease
Value to the healthcare system, branding and success in competing in competitive environments and ensuring optimal patient care all play a role in defining the value of vascular surgeons to both hospital leadership and patients. Richard Powell, MD, Joseph Mills,…
Who will you see in the Exhibit Hall this year?
Be sure to schedule plenty of time to visit the Exhibit Hall during this year’s live and in-person Vascular Annual Meeting (VAM). The Exhibit Hall will be open 10 a.m. Thursday, Aug. 19, through Friday, Aug. 20, and will feature…
VQI@VAM: Celebrating science, quality and VQI’s 10th anniversary
The Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) will host a day and a half of sessions aimed at quality improvement at its annual meeting, held in conjunction with the SVS Vascular Annual Meeting (VAM). VQI@VAM runs from…
Carotid endarterectomy shows ‘improved long-term durability’ over transfemoral carotid artery stenting
An increased postoperative stroke rate associated with transfemoral carotid artery stenting “seems to extend up to five years’ follow-up” compared to carotid endarterectomy. This is the conclusion set to be presented by Kevin S. Yei, BS, of the University of…
Introducing patient-reported outcomes into the VQI
Vascular specialists have long recognized that there is more to the treatment of peripheral arterial disease (PAD) than the immediate procedural success and early outcomes. The patient experience should not only be measured in clinical outcomes such as patency or…
Fempop bypass shows reintervention benefit over endovascular therapy for advanced premature PAD
Femoropopliteal bypass is associated with decreased reinterventions at one year compared to endovascular therapy in patients with advanced premature peripheral arterial disease (PAD). This is the primary conclusion of Tanner I. Kim, MD, an integrated vascular surgery resident at Yale School…
Stenting found to be superior to atherectomy, balloon angioplasty in reducing PAD mortality risk
Stenting reduced mortality risk in patients undergoing interventions for peripheral arterial disease (PAD) by more than 30% when compared to plain balloon angioplasty, and 40% contrasted with atherectomy, a recent propensity-matched analysis found. The Vascular Quality Initiative (VQI)-derived data drew…
TCAR vs CEA: Research shows fewer myocardial infarctions after TCAR with use of general anesthesia
A Vascular Quality Initiative (VQI) analysis uncovered a reduction in the risk of myocardial infarction after transcarotid artery revascularization (TCAR) compared to carotid endarterectomy (CEA) when general anesthesia is used—an observation mainly found in patients with symptomatic carotid artery stenosis.…
Interventions associated with ‘poor’ two-year relief of intermittent claudication symptoms
Peripheral vascular interventions for intermittent claudication were linked to “poor” two-year relief of symptoms in the Vascular Quality Initiative (VQI) database, a new study published in the May issue of the Journal of Vascular Surgery (JVS) found. First-named author Jonathan…